Gene · 4205
Papers4,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease. | bioRxiv | 2024 | 39803522 | PubTator, text mining | PubMed |
| Maternal high-fat diet orchestrates offspring hepatic cholesterol metabolism via MEF2A hypermethylation-mediated CYP7A1 suppression. | Cell Mol Biol Lett | 2024 | 39695937 | PubTator, text mining | PubMed |
| Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer. | J Clin Invest | 2024 | 39688912 | PubTator, text mining | PubMed |
| Perinuclear compartment controls calcineurin/MEF2 signaling for axonal outgrowth of hippocampal neurons. | Front Mol Neurosci | 2024 | 39654556 | PubTator, text mining | PubMed |
| An adult myogenic cell line of the Japanese fire-bellied newt Cynops pyrrhogaster. | Sci Rep | 2024 | 39627485 | PubTator, text mining | PubMed |
| TriTan: an efficient triple nonnegative matrix factorization method for integrative analysis of single-cell multiomics data. | Brief Bioinform | 2024 | 39581871 | PubTator, text mining | PubMed |
| African origin haplotype protective for Alzheimer's disease in APOEε4 carriers: exploring potential mechanisms. | bioRxiv | 2024 | 39484566 | PubTator, text mining | PubMed |
| Twist-related protein 1 promotes transforming growth factor β receptor 1 in keloid fibroblasts via regulating the stability of myocyte enhancer factor 2A. | Burns Trauma | 2024 | 39429644 | PubTator, text mining | PubMed |
| Context transcription factors establish cooperative environments and mediate enhancer communication. | Nat Genet | 2024 | 39363017 | PubTator, text mining | PubMed |
| Aerobic Exercise Protects against Cardiotoxin-Induced Skeletal Muscle Injury in a DDAH1-Dependent Manner. | Antioxidants (Basel) | 2024 | 39334728 | PubTator, text mining | PubMed |
| MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia. | Int J Oncol | 2024 | 39329212 | PubTator, text mining | PubMed |
| The role of RNA modifications in disease-associated macrophages. | Mol Ther Nucleic Acids | 2024 | 39296330 | PubTator, text mining | PubMed |
| AI approaches for the discovery and validation of drug targets. | Camb Prism Precis Med | 2024 | 39258224 | PubTator, text mining | PubMed |
| Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal. | Psychopharmacology (Berl) | 2024 | 39254835 | PubTator, text mining | PubMed |
| Overview of pro-inflammatory and pro-survival components in neuroinflammatory signalling and neurodegeneration. | Ageing Res Rev | 2024 | 39187022 | PubTator, text mining | PubMed |
| AQP1 differentially orchestrates endothelial cell senescence. | Redox Biol | 2024 | 39180980 | PubTator, text mining | PubMed |
| The MEF2A/SNHG16/miR-425-5p/NOTCH2 axis induces gemcitabine resistance by inhibiting ferroptosis in the starving bladder tumor microenvironment. | Cell Signal | 2024 | 39121977 | PubTator, text mining | PubMed |
| Molecular tools to capture active neural circuits. | Front Neural Circuits | 2024 | 39100199 | PubTator, text mining | PubMed |
| m6A-mediated HDAC9 upregulation promotes particulate matter-induced airway inflammation via epigenetic control of DUSP9-MAPK axis and acts as an inhaled nanotherapeutic target. | J Hazard Mater | 2024 | 39088948 | PubTator, text mining | PubMed |
| Molecular aspects of the exercise response and training adaptation in skeletal muscle. | Free Radic Biol Med | 2024 | 39059515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4205/papers?page=7